Macromolecular contrast agents (CAs) usually possess excellent contrast ability and tumor-targeting ability in comparison with small-molecule CAs, especially for early tumor detection. Herein, cyclodextrin-conjugated low-molecular-weight polyethyleneimine was synthesized as a macromolecular backbone. Afterward, a linear polymer with adamantane terminal and Gd chelates was synthesized, followed by conjugating with the backbone host-guest interaction. Finally, folic acid was conjugated onto the as-prepared CAs through bioorthogonal chemistry, which endowed the CAs with the capability to accumulate into the tumor region. Compared to Magnevist ( = 4.25 mM s) used in clinic, the PC/Ad-PEG-PLL(DTPA-Gd)-FA exhibited higher longitudinal relaxivity ( = 11.62 mM s) with excellent biocompatibility. Furthermore, experiments demonstrated that PC/Ad-PEG-PLL(DTPA-Gd)-FA could effectively accumulate in the tumor region and produce a brighter image than that of Magnevist. The H&E staining and metabolic data further illustrated that this CA possessed excellent biocompatibility . Finally, these results above suggest that this macromolecular CA could be a potential candidate as a MRI CA for tumor-targeted diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985534PMC
http://dx.doi.org/10.1039/d4ra00316kDOI Listing

Publication Analysis

Top Keywords

cyclodextrin-conjugated low-molecular-weight
8
low-molecular-weight polyethyleneimine
8
macromolecular contrast
8
accumulate tumor
8
tumor region
8
excellent biocompatibility
8
macromolecular
4
polyethyleneimine macromolecular
4
contrast agent
4
agent tumor-targeted
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!